References
- Bradbeer T. M., Fleming P. M., Charlton P., Crichton J. S. Survey of amphetamine prescribing in England and Wales. Drug and Alcohol Review 1998; 17: 299–304
- British Medical Association. Smoking and Reproductive Life: the impact of smoking on sexual, reproductive and child health. BMA publications, London 2004
- Charnaud B., Griffiths V. Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison. Drug & Alcohol Dependence 1998; 52: 79–84
- Cox D., Bowers R., McBride A. Reboxetine may be helpful in the treatment of amphetamine withdrawal: a series of eleven cases. British Journal of Clinical Pharmacology 2004; 58: 100–101
- Dawe S., Gerada C., Strang J. Establishment of a liaison service for pregnant opiate‐dependent women. British Journal of Addiction 1992; 87: 867–871
- Dearlove J. C., Betteridge T. J., Henry J. A. Stillbirth due to intravenous amphetamine. British Medical Journal 1992; 304((6826))548
- Department of Health. Drug Misuse and Dependence—Guidelines on Clinical Management. HMSO, London 1999
- Eriksson M. Amphetamine addiction and pregnancy. Acta Obstetricia et Gynecologica Scandinavica 1981; 60((3))253–259
- Eriksson M., Jonsson B., Steneroth G., Zetterström R. Cross‐sectional growth of children whose mothers abused amphetamines during pregnancy. Acta Paediatrica Scandinavica 1994; 83: 613–614
- Eriksson M., Zetterstrom R. Amphetamine addiction during pregnancy: 10 year follow‐up. Acta Paediactrica 1994; 83(Suppl. 404)27–31
- Gillogley K. M., Evans A. T., Hansen R. L., Samuels S. J., Batra K. K. The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intra‐partum screening. American Journal of Obstetrics and Gynecology 1990; 163: 1535–1542
- Grabowski R., Rhoades H., Schmitz J., Stotts A., Anndaruzska L., Creson D., Moeller F. Dextroamphetamine for cocaine‐dependence treatment: a double‐blind randomised clinical trial. Journal of Clinical Psychopharmacology 2001; 21: 522–526
- Heinonen P., Slone D., Shapiro S. Birth Defects and Drugs in Pregnancy. Publishing Sciences Group Inc, Littleton 1977
- Hulse G. K., Milne E., English R., Holman C. D. J. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 1997; 92: 1571–1579
- Klee H. A new target for behavioural research—amphetamine misuse. British Journal of Addiction 1992; 87: 439–446
- Klee H. HIV risks for women drug injectors: heroin and amphetamine users compared. Addiction 1993; 88: 1055–1062
- Little B. B., Snell L. M., Gilstrap L. C. Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstetrics and Gynecology 1988; 72: 541–544
- Ludlow J. P., Evans S. F., Hulse G. Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse. Australian and New Zealand Journal of Obstetrics and Gynaecology 2004; 44: 302–306
- Milkovich L., van den Berg B. Effects of antenatal exposure to anorectic drugs. American Journal of Obstetrics and Gynecology 1977; 129: 637–641
- Naeye R. L. Maternal use of dextroamphetamine and growth of fetus. Pharmacology 1983; 26: 117–120
- Nelson M. M., Forfar J. O. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. British Medical Journal 1971; 1: 523–527
- Nora J. J., McNamara D. G., Fraser F. C. Dexamphetamine sulphate and human malformation. Lancet 1967; i: 570–571
- Nora J. J., Vargo T. A., Nora A., Love K. E., McNamara D. G. Dexamphetamine: a possible environmental trigger in cardiovascular malformations. Lancet 1970; i: 1290–1291
- Plessinger M. A. Prenatal exposure to amphetamines. Obstetrics Gynecology Clinics of North America 1998; 25: 120–126
- Scully M., Geoghegan N., Corcoran P., Tiernan M., Keenan E. Specialized drug liaison midwife services for pregnant opioid dependent women in Dublin, Ireland. Journal of Substance Abuse Treatment 2004; 26: 329–335
- White R. Dexamphetamine substitution in the treatment of amphetamine abuse: an initial investigation. Addiction 2000; 95: 229–238